As of August 21, 2026 6:55pm CDT, LLY (Eli Lilly & Co., XNYS) traded at $1,254.06, +9.81 (+0.79%) on the day (delayed quote). StockMarketLoop's Market Position model puts the current profit ratio at 93.28%, with support near $1,206.47 and resistance near $1,258.58. Market capitalization: $1,109.2B.

Source: StockMarketLoop real-time market data (massive-aggregates-fallback-5m). Not investment advice.

LLY

Eli Lilly & Co.

XNYS · CS

$1,254.06 +0.79% Delayed market data
Volume1,872,765
Market cap$1,109.2B
Market position93.28%
Support / resistance$1,206.47 / $1,258.58

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Explore LLY

Open the interactive ticker terminal for charts, technical tools, market discussion and live modules.

Open LLY ticker terminal
Observed August 21, 2026 6:55 pm CDT. Market data and model estimates only—not investment advice.
Stock Market LoopConnect. Learn. Share. Grow.
Stock Market Loop
Join StockmarketloopSign in to post, vote sentiment, save watchlists and view member tools.